tradingkey.logo

LifeMD Inc

LFMD
3.220USD
-0.010-0.31%
交易中 美东报价延迟15分钟
150.00M总市值
亏损市盈率 TTM

LifeMD Inc

3.220
-0.010-0.31%

关于 LifeMD Inc 公司

LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.

LifeMD Inc简介

公司代码LFMD
公司名称LifeMD Inc
上市日期Jul 11, 2001
CEOSchreiber (Justin)
员工数量304
证券类型Ordinary Share
年结日Jul 11
公司地址236 Fifth Avenue
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编10001
电话18663515907
网址https://lifemd.com/
公司代码LFMD
上市日期Jul 11, 2001
CEOSchreiber (Justin)

LifeMD Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Justin Schreiber
Mr. Justin Schreiber
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
2.85M
+7.23%
Mr. Stefan Galluppi
Mr. Stefan Galluppi
Chief Innovation Officer
Chief Innovation Officer
1.79M
+1.71%
Mr. Nicholas P. Alvarez
Mr. Nicholas P. Alvarez
Chief Acquisition Officer
Chief Acquisition Officer
495.71K
-13.14%
Mr. William J. (Will) Febbo
Mr. William J. (Will) Febbo
Director
Director
480.00K
+88.24%
Ms. Jessica Friedeman
Ms. Jessica Friedeman
Chief Marketing Officer
Chief Marketing Officer
220.00K
+29.41%
Mr. Roberto (Bob) Simon
Mr. Roberto (Bob) Simon
Independent Director
Independent Director
153.18K
+17.10%
Mr. Dennis Wijnker
Mr. Dennis Wijnker
Chief Technology Officer
Chief Technology Officer
135.00K
+22.73%
Dr. Joan Larovere
Dr. Joan Larovere
Independent Director
Independent Director
107.05K
+26.41%
Mr. Shane Biffar
Mr. Shane Biffar
Chief Compliance Officer and Deputy General Counsel
Chief Compliance Officer and Deputy General Counsel
40.00K
-73.33%
Mr. Calum Macrae, M.D., Ph.D.
Mr. Calum Macrae, M.D., Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Justin Schreiber
Mr. Justin Schreiber
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
2.85M
+7.23%
Mr. Stefan Galluppi
Mr. Stefan Galluppi
Chief Innovation Officer
Chief Innovation Officer
1.79M
+1.71%
Mr. Nicholas P. Alvarez
Mr. Nicholas P. Alvarez
Chief Acquisition Officer
Chief Acquisition Officer
495.71K
-13.14%
Mr. William J. (Will) Febbo
Mr. William J. (Will) Febbo
Director
Director
480.00K
+88.24%
Ms. Jessica Friedeman
Ms. Jessica Friedeman
Chief Marketing Officer
Chief Marketing Officer
220.00K
+29.41%
Mr. Roberto (Bob) Simon
Mr. Roberto (Bob) Simon
Independent Director
Independent Director
153.18K
+17.10%

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Schreiber (Justin)
5.93%
BlackRock Institutional Trust Company, N.A.
5.21%
The Vanguard Group, Inc.
4.63%
Galluppi (Stefan)
3.71%
Renaissance Technologies LLC
3.39%
其他
77.13%
持股股东
持股股东
占比
Schreiber (Justin)
5.93%
BlackRock Institutional Trust Company, N.A.
5.21%
The Vanguard Group, Inc.
4.63%
Galluppi (Stefan)
3.71%
Renaissance Technologies LLC
3.39%
其他
77.13%
股东类型
持股股东
占比
Investment Advisor
20.73%
Individual Investor
17.81%
Investment Advisor/Hedge Fund
10.75%
Hedge Fund
7.90%
Research Firm
2.96%
Venture Capital
0.28%
Pension Fund
0.27%
Bank and Trust
0.09%
Insurance Company
0.03%
其他
39.17%

机构持股

更新时间: 10月5日 周日
更新时间: 10月5日 周日
报告期
机构数
持股数
持股占比
持股变动
2025Q3
277
24.14M
53.61%
+2.76M
2025Q2
267
25.16M
55.86%
-4.75M
2025Q1
265
25.52M
57.64%
-4.18M
2024Q4
250
23.83M
55.01%
-4.80M
2024Q3
242
24.90M
57.80%
-2.33M
2024Q2
218
23.83M
56.29%
-290.09K
2024Q1
179
22.61M
56.88%
+2.36M
2023Q4
165
20.18M
54.63%
+3.17M
2023Q3
148
17.40M
50.33%
+1.98M
2023Q2
144
16.05M
50.66%
-1.42M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Schreiber (Justin)
2.85M
6.34%
+192.34K
+7.23%
Apr 23, 2025
BlackRock Institutional Trust Company, N.A.
2.41M
5.35%
+107.80K
+4.68%
Jun 30, 2025
The Vanguard Group, Inc.
2.09M
4.63%
+205.62K
+10.93%
Jun 30, 2025
Galluppi (Stefan)
1.79M
3.96%
+30.00K
+1.71%
Aug 22, 2025
Renaissance Technologies LLC
1.09M
2.41%
+600.10K
+123.45%
Jun 30, 2025
Nuveen LLC
1.14M
2.53%
+854.91K
+300.99%
Jun 30, 2025
State Street Investment Management (US)
1.14M
2.53%
+413.24K
+57.01%
Jun 30, 2025
Geode Capital Management, L.L.C.
925.17K
2.05%
+67.44K
+7.86%
Jun 30, 2025
UBS Financial Services, Inc.
937.33K
2.08%
+859.44K
+1103.45%
Jun 30, 2025
Royce Investment Partners
770.45K
1.71%
-384.78K
-33.31%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
State Street SPDR S&P Kensho New Econ Comp ETF
0.09%
Vanguard US Multifactor ETF
0.08%
Vanguard US Momentum Factor ETF
0.06%
Principal U.S. Small-Cap ETF
0.06%
iShares Micro-Cap ETF
0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
WisdomTree US SmallCap Quality Growth Fund
0.02%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
查看更多
State Street SPDR S&P Kensho New Econ Comp ETF
占比0.09%
Vanguard US Multifactor ETF
占比0.08%
Vanguard US Momentum Factor ETF
占比0.06%
Principal U.S. Small-Cap ETF
占比0.06%
iShares Micro-Cap ETF
占比0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
占比0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.03%
WisdomTree US SmallCap Quality Growth Fund
占比0.02%
iShares Russell 2000 Growth ETF
占比0.01%
Global X Russell 2000 ETF
占比0.01%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

LifeMD Inc的前五大股东是谁?

LifeMD Inc 的前五大股东如下:
Schreiber (Justin)持有股份:2.85M,占总股份比例:6.34%。
BlackRock Institutional Trust Company, N.A.持有股份:2.41M,占总股份比例:5.35%。
The Vanguard Group, Inc.持有股份:2.09M,占总股份比例:4.63%。
Galluppi (Stefan)持有股份:1.79M,占总股份比例:3.96%。
Renaissance Technologies LLC持有股份:1.09M,占总股份比例:2.41%。

LifeMD Inc的前三大股东类型是什么?

LifeMD Inc 的前三大股东类型分别是:
Schreiber (Justin)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

有多少机构持有LifeMD Inc(LFMD)的股份?

截至2025Q3,共有277家机构持有LifeMD Inc的股份,合计持有的股份价值约为24.14M,占公司总股份的53.61%。与2025Q2相比,机构持股有所增加,增幅为-2.25%。

哪个业务部门对LifeMD Inc的收入贡献最大?

在--,--业务部门对LifeMD Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI